PV-10 Trademark

Trademark Overview

On Thursday, June 25, 2015, a trademark application was filed for PV-10 with the United States Patent and Trademark Office. The USPTO has given the PV-10 trademark a serial number of 86674807. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 7, 2023. This trademark is owned by Provectus Pharmatech, Inc. The PV-10 trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of cancers, melanoma, breast cancer, basal cell carcinoma, squamous cell carcinoma and cancers of the liver
pv-10

General Information

Serial Number86674807
Word MarkPV-10
Filing DateThursday, June 25, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 7, 2023
Registration Number5096447
Registration DateTuesday, December 6, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements

Pseudo MarkPV-TEN
Goods and ServicesMedicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of cancers, melanoma, breast cancer, basal cell carcinoma, squamous cell carcinoma and cancers of the liver

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 2, 2015
Primary Code005
First Use Anywhere DateFriday, July 22, 2005
First Use In Commerce DateFriday, July 22, 2005

Trademark Owner History

Party NameProvectus Pharmatech, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKnoxville, TN 37929
Party NameProvectus Pharmatech, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKnoxville, TN 37931
Party NameProvectus Pharmatech, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKnoxville, TN 37931

Trademark Events

Event DateEvent Description
Monday, June 29, 2015NEW APPLICATION ENTERED
Thursday, July 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 3, 2015NOTICE OF PSEUDO MARK E-MAILED
Thursday, October 1, 2015ASSIGNED TO EXAMINER
Friday, October 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016TEAS STATEMENT OF USE RECEIVED
Monday, April 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 8, 2016USE AMENDMENT FILED
Monday, April 18, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, April 18, 2016SU - NON-FINAL ACTION - WRITTEN
Monday, April 18, 2016NON-FINAL ACTION E-MAILED
Monday, April 18, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2016ASSIGNED TO LIE
Thursday, October 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 28, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 29, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, August 1, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 2, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 7, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 7, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, December 6, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

carcinoma cell cancers pharmaceutical preparations basal squamous liver cancer breast